Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$11.55
+7.04%
Mkt Cap $578.71M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (14 analysts)
$24.83
Range $19.00 – $36.00
Implied Upside
+115.0%
Consensus $24.83 vs current $11.55
NASDAQ·Healthcare·Biotechnology
$11.55
+7.04%
Mkt Cap $578.71M
Buy
1
Hold
0
Sell
0
Price Target (14 analysts)
$24.83
Range $19.00 – $36.00
+115.0%
Consensus $24.83 vs current $11.55